Efectividad de la vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario
Authors:
- Pablo Chico-SánchezPCPablo Chico-Sánchez
- Paula Gras-ValentíPGPaula Gras-Valentí
- Natividad Algado-SellésNANatividad Algado-Sellés
- Esperanza Merino-LucasEMEsperanza Merino-Lucas
- Juan Carlos Rodríguez-DíazJRJuan Carlos Rodríguez-Díaz
- Elena Ronda-PérezERElena Ronda-Pérez
- José Sánchez-PayáJSJosé Sánchez-Payá
Open Access
- 26 November 2021
- journal article
- research article
- Published by Elsevier in Gaceta Sanitaria
- Vol. 36 (5) , 484-487
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021Eurosurveillance, 2021
- Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021Eurosurveillance, 2021
- Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort studyThe Lancet, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- The case test-negative design for studies of the effectiveness of influenza vaccineVaccine, 2013